Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: An analysis of 109 pregnancies in 225 women

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 3821-3824

  White, Davinia M ^a   Polson, David W ^a   Kiddy, Deborah ^a   Sagle, Peggy ^a   Watson, Hazel ^a   Gilling Smith, Carole ^a   Hamilton Fairley, Diana ^a   Franks, Stephen ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GESTAGEN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; BODY MASS; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ADULT; CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY, MULTIPLE;

EID: 0029795318     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.3821     Document Type: Article

References (28)

1. Hull MGR. 1987 Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol. 1:235-245.
2. Hull MGR. 1992 The causes of infertility and relative effectiveness of treatment. In: Templeton AA, Drife JO, eds. Infertility. London: Springer-Verlag; 33-62.
3. Franks S, Adams J, Mason H, Polson D. 1985 Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynecol. 12:605-632.
4. Lunenfeld B, Insler V. 1978 Diagnosis and treatment of functional infertility. Berlin: Gross Verlag.
5. Wang CF, Gemzell C. 1980 The use of human gonadotropins for induction of ovulation in women with polycystic ovarian disease. Fertil Steril. 33:479-486.
6. Kamrava MM, Seibel MM, Berger MJ, Thompson I, Taymor ML. 1982 Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose follicle-stimulating hormone. Fertil Steril. 37:520-523.
7. Seibel MM, McArdle C, Smith D, Taymor ML. 1985 Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin. Fertil Steril. 43:703-708.
8. Poison DW, Mason HD, Saldahna MB, Franks S. 1987 Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 26:205-212.
9. Sagle MA, Hamilton-Fairley D, Kiddy DS, Franks S. 1991 A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil Steril. 55:56-60.
10. Hamilton-Fairley D, Kiddy D, Watson H, Sagle M, Franks S. 1991 Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum Reprod. 6:1095-1099.
11. Hamilton-Fairley D, Kiddy D, Watson H, Paterson C, Franks S. 1992 Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol. 99:128-131.
12. Brown JB. 1978 Pituitary control of ovarian function-concepts derived from gonadotrophin therapy. Aust NZ J Obstet Gynaecol. 18:47-54.
13. Adams J, Poison DW, Franks S. 1986 Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J. 293:355-359.
14. Salat-Baroux J, Antoine JM. 1990 Accidental hyperstimulation during ovulation induction. Bailliere Clin Obstet Gynaecol. 4:627-637.
15. Regan L, Braude PR, Trembath PL. 1989 Influence of past reproductive performance on risk of spontaneous abortion. Br Med J. 299:541-545.
16. Buvat J, Buvat HM, Marcolin G, Dehaene JL, Verbecq P, Renouard O. 1989 Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertil Steril. 52:553-559.
17. Shoham Z, Patel A, Jacobs HS. 1991 Polycystic ovary syndrome; safety and effectiveness of a stepwise and low-dose administration of purified FSH. Fertil Steril. 55:1051-1056.
18. Hoffman DI, Lobo RA, Campeau JD, et al. 1985 Ovulation induction in Clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) vs. purified urinary FSH and luteinizing hormone. J Clin Endocrinol Metab. 60:922-927.
19. Venturoli S, Paradisi R, Fabbri R, et al. 1987 Induction of ovulation in polycystic ovary: human menopausal gonadotrophin or human urinary follicle stimulating hormone? Int J Fertil. 32:66-70.
20. Larsen T, Bostofte E, Larsen JF, et al. 1990 Comparison of urinary follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovary syndrome. Fertil Steril. 53:426-31.
21. Fleming R, Haxton MJ, Hamilton MPR, et al. 1985 Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins. Br J Obstet Gynaecol. 92:369-379.
22. Balen AR, Tan SL, Jacobs HS. 1993 Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. Br J Obstet Gynaecol. 100:1082-1089.
23. Dodson WC, Hughes CJ, Yancy SE, Haney AF. 1989 Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome. Fertil Steril. 5:915-918.
24. Homburg R, Eshel A, Kilborn J, Adams J, Jacobs HS. 1990 Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Hum Reprod. 5:32-35.
25. Franks S, Hamilton-Fairley D. 1996 Ovulation induction: gonadotropins. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive endocrinology: surgery and technology. New York: Raven Press; 1207-1224.
26. McClure N, McQuinn B, McDonald J, Kovacs GT, Healy DL, Burger HG. 1992 Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome? Fertil Steril. 58:622-622.
27. Kiddy DS, Hamilton-Fairley D, Bush A, et al. 1992 Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 36:105-111.
28. Balen AH, Braat DDM, West C, et al. 1994 Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Hum Reprod. 9:1563-1567.